In Vitro Diagnostic (IVD) Directive loses human tissue element
This article was originally published in Clinica
A decision has been agreed which will allow work on the European Union's draft IVD Directive to go ahead. Clauses relating to the regulation of human tissues have been separated from the main body of the draft. The decision was made on October 15, at the meeting of the Committee of Permanent Representatives, which assists the European Council of Ministers.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.